丹酚酸A

46. [IF=3.1] Huihui Chen, et al. "Uncovering the active substances of Modified Fangjihuangqi Decoction in reducing cardiomyocytes’ mitochondrial oxidative damage"JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2026 Mar;:117493 45. [IF=5.4] Huiru Liu, et al. "Mechanisms and key active ingredients of HeDan capsules in ameliorating MASLD via bile acid metabolism regulation"JOURNAL OF ETHNOPHARMACOLOGY, 2026 Jul;366:121639 44. [IF=5.7] Zhuang Xuefeng, et al. "Qinggan Jianpi formula attenuates atherosclerosis by suppressing macrophage lactate transport to activate repair genes via H3K18 lactylation"Chinese Medicine, 2026 Dec;21(1):121 43. [IF=5.2] Ying Xu, et al. "Targeting pancreatic cancer progression: The formononetin and salvianolic acid B combination suppresses JAK/STAT signaling via MBOAT2 downregulation"Journal of Integrative Medicine-JIM, 2026 May;: 42. [IF=2.2] Li Lin et al."Salvianolic acid A reduces lipotoxicity injury of cardiomyocytes by orchestrating oxidative stress and inflammation via Akt/Nrf2/NF-κB axis."JOURNAL OF MOLECULAR HISTOLOGY.2026 Feb;57(1):12 41. [IF=3.6] Yuanlin Luo et al."Deciphering Anticoagulant Active Substances and Mechanisms in Guanxinjing Formula Through Phenotype-Anchored Hierarchical Strategy and Topological Network Analysis."ARCHIV DER PHARMAZIE.2026 Jan;359(1):e70181 40. [IF=5.7] Ding Menglei et al."Targeting G-protein-coupled receptors and gut microbiota: Ge-Lian Qi-Shen decoction elevates GLP-1 to combat non-alcoholic fatty liver disease."Chinese Medicine.2026 Dec;21(1):51 39. [IF=1.6] Wei Liu et al."Determination of Phenolic Acids in Salvia miltiorrhiza by Vortex-Assisted Matrix Solid-Phase Dispersion Coupled With High-Performance Liquid Chromatography."Separation Science Plus.2025 Nov;8(11):e70161 38. [IF=2.6] Xiaoqian Huo et al."Mechanism analysis of Salvia miltiorrhiza Bunge (Danshen) on circadian rhythm for treating myocardial injury by mathematic model."FITOTERAPIA.2025 Oct;186:106782 37. [IF=2.6] Xiaoqian Huo et al."Mechanism analysis of Salvia miltiorrhiza Bunge (Danshen) on circadian rhythm for treating myocardial injury by mathematic model."FITOTERAPIA.2025 Oct;186:106782 36. [IF=8.2] Yao Chen et al."Biomimetic Platelet Membrane-Based Polyphenol–CeO2 Nanozyme Complex: A Broad-Spectrum Antioxidative System for Comprehensive Atherosclerosis Treatment."ACS Applied Materials & Interfaces.2025;17(30):43536–43552 35. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253 34. [IF=8.1] Qiu Xiaoxiao et al."Smi-miRmTERF regulates organelle development, retrograde signaling, secondary metabolism and immunity via targeting a subset of SmmTERFs in Salvia miltiorrhiza."Molecular Horticulture.2025 Dec;5(1):1-25 33. [IF=5.7] Yue Wang et al."Precise Molecularly Imprinted Montmorillonite for Selective Adsorption of Salvianolic Acid A with Ultra-large Capacity."Surfaces and Interfaces.2025 Jan;:105741 32. [IF=3.7] Mingxi Zhang et al."Development of a Multienzyme Cascade for Salvianolic Acid A Synthesis from l-Tyrosine."ACS Omega.2025;XXXX(XXX):XXX-XXX 31. [IF=4.8] Zhengchao Ji et al."Holistic quality assessment and monitoring of YiXinShu capsule based on three-dimensional fingerprints combined with quantitative analysis, antioxidant activity and chemometrics."JOURNAL OF ETHNOPHARMACOLOGY.2024 Dec;335:118630 30. [IF=6.7] Ziyuan Zhao et al."Pretreatment with Dan-Shen-Yin granules alleviates ethanol-induced gastric mucosal damage in rats by inhibiting oxidative stress and apoptosis via Akt/Nrf2 signaling pathway."PHYTOMEDICINE.2024 Jul;:155866 29. [IF=2.8] Ning Liu et al."Pharmacodynamic and metabonomic studies on the improvement of DR with Fufang Xueshuantong component compatibility."JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES.2024 Jun;:124194 28. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692 27. [IF=3.3] Shuai Huang et al."Salvianolic acid A improves nerve regeneration and repairs nerve defects in rats with brain injury by downregulating miR-212-3p-mediated SOX7."KAOHSIUNG JOURNAL OF MEDICAL SCIENCES.2023 Nov;: 26. [IF=3.8] Minhang Dou et al."HPLC combined with chemometrics for quality control of Huamoyan Granules or Capsules."Chinese Herbal Medicines.2023 Jul;: 25. [IF=4.6] Jun Qian et al."Comparison of Salvianolic Acid A Adsorption by Phenylboronic-Acid-Functionalized Montmorillonites with Different Intercalators."MOLECULES.2023 Jan;28(13):5244 24. [IF=4.4] Mengmeng Zheng et al."Chemoproteomics and Phosphoproteomics Profiling Reveals Salvianolic Acid A as a Covalent Inhibitor of mTORC1."JOURNAL OF PROTEOME RESEARCH.2023;22(7):2450–2459 23. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396 22. [IF=9.429] Zhang Bing et al."The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A."JOURNAL OF NANOBIOTECHNOLOGY.2022 Dec;20(1):1-20 21. [IF=3.935] Yaqing Guo et al."An integrated strategy for the systematic chemical characterization of Salvianolate lyophilized injection using four scan modes based on the ultra-high performance liquid chromatography-triple quadrupole-linear ion trap mass spectrometry. 20. [IF=9.078] Jun Qian et al."A strategy for effective recovery of salvianolic acid a from Salvia miltiorrhiza (Danshen) through multiple interactions."Compos Part B-Eng. 2022 Feb;231:109563 19. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 18. [IF=3.216] Shuang Feng et al."Salvianolic Acid A Exhibits Anti-Inflammatory and Antiarthritic Effects via Inhibiting NF-κB and p38/MAPK Pathways."Drug Des Dev Ther. 2020; 14: 1771–1778 17. [IF=2.943] Zheng Chunli et al."System-level multi-target drug discovery from natural products with applications to cardiovascular diseases."Mol Divers. 2014 Aug;18(3):621-635 16. [IF=3.049] Jixia Wang et al."Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay."Rsc Adv. 2015 Mar;5(33):25768-25776 15. [IF=4.759] Yanmei Zhang et al."Screening of mammalian target of rapamycin inhibitors in natural product extracts by capillary electrophoresis in combination with high performance liquid chromatography–tandem mass spectrometry."J Chromatogr A. 2015 Apr;1388:267 14. Zhou, Jing, et al. "A strategy for rapid discovery of traceable chemical markers in herbal products using MZmine 2 data processing toolbox: A case of Jing Liqueur." Chinese Herbal Medicines (2021). 13. Wang, Jixia, et al. "Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay." RSC Advances 5.33 (2015): 25768-25776.https://doi.org/10.1039/C4RA16102E 12. 乐世俊,王文晓,高欢,任继国,付瑞嘉,李佳佳,陈艳琰,唐于平.HPLC同时测定不同厂家丹七片中多个有效成分的含量[J].药物分析杂志,2020,40(12):2236-2243. 11. 黑小斌,李欢,李慧,梁小燕,高静,彭亮,李依民,张岗.丹参无菌培养体系构建及有效成分含量的HPLC分析[J].中草药,2020,51(22):5833-5838. 10. 王芸, 陈军峰, 张磊,等. 基于"有效成分-性状"的关联分析评价丹参品质的研究[J]. 世界科学技术:中医药现代化, 2019(5):835-843. 9. 赵志国, 段文娟, 张晓梦,等. HPLC-DAD-ESI-TOF/MS鉴别和测定前列欣胶囊中多种成分及其多指标定量指纹图谱研究[J]. 药物分析杂志, 2017, 037(010):1810-1816. 8. 李正, 潘万芳, 朱立明,等. 基于物质流分析的丹红注射液制药过程质量控制研究[J]. 天津中医药大学学报, 2015, 34(06):349-352. 7. 马东来 刘爱朋 林悦 谢赟 刘涛 朱峰莉 楚立.丹参有效成分与铁离子的相互作用[J].广州化工 2017 45(14):117-118+144. 6. 冯思念 王瑞 顾雯 等. 不同强度的红蓝光质对丹参根系形态和有效成分积累的影响[J]. 中草药 2019(21). 5. 邢志华, 包然, 姜婧雯,等. 芹菜素-钐配合物的合成及其抗小鼠高尿酸血症研究. 天然产物研究与开发. 4. 黄莎莎 赵文静 张悦 等. 中药酚酸类成分在PES膜分离过程中的透过机制研究[J]. 中国中药杂志 2020 v.45(01):114-120. 3. 彭九嫚, 柴尧, 潘旻,等. 丹参中酚酸类成分在不同工艺条件下转化关系[J]. 中国实验方剂学杂志, 2016, 022(005):67-70. 2. 姜峰 李飏 张敏 等. 丹参中丹酚酸A转化方法[J]. 中成药 2018 40(009):2091-2096. 1. 张素清 虞立 范红晶 等. 丹参中丹酚酸A在高温高压条件下的转化提取工艺研究[J]. 中华中医药学刊 2017 035(012):3084-3087.